Potentiation of antibacterial activity of azithromycin and other macrolides by normal human serum.
about
Expedient Synthesis of SMAMPs via Click Chemistry.Synthetic peptides that exert antimicrobial activities in whole blood and blood-derived matricesImpact of a low-oxygen environment on the efficacy of antimicrobials against intracellular Chlamydia trachomatis.Beneficial influence of platelets on antibiotic efficacy in an in vitro model of Staphylococcus aureus-induced endocarditis.Azithromycin Synergizes with Cationic Antimicrobial Peptides to Exert Bactericidal and Therapeutic Activity Against Highly Multidrug-Resistant Gram-Negative Bacterial Pathogens.Exploiting translational stalling peptides in an effort to extend azithromycin interaction within the prokaryotic ribosome nascent peptide exit tunnel.Albumin Enhances Caspofungin Activity against Aspergillus Species by Facilitating Drug Delivery to Germinating Hyphae.Pharmacokinetics and pharmacodynamics in antibiotic dose optimization.A large potentiation effect of serum on the in vitro potency of tulathromycin against Mannheimia haemolytica and Pasteurella multocida.Effect of human serum on killing activity of vancomycin and teicoplanin against Staphylococcus aureus.New macrolide antibiotics: usefulness in infections caused by mycobacteria other than Mycobacterium tuberculosis.Macrolides and β-lactam antibiotics enhance C3b deposition on the surface of multidrug-resistant Streptococcus pneumoniae strains by a LytA autolysin-dependent mechanism.Pharmacodynamic Evaluation and PK/PD-Based Dose Prediction of Tulathromycin: A Potential New Indication for Streptococcus suis Infection.Pharmacokinetics and lung tissue concentrations of tulathromycin in swine.Seventy-five years of research on protein binding - do we ever understand?
P2860
Q33749813-6DD39A25-D975-460B-BB8E-DAE440A3224FQ34252687-69911E95-8DD3-4894-BC34-01EA347C1CA0Q34932613-BBC3ABF0-A510-403E-8C18-65489FA19E68Q35124661-83C5068D-99FB-4469-9871-1DCD250EB657Q35947509-0C871D7E-8226-4B4C-8070-5BD471715F4BQ35952044-254FF07D-39F7-4B64-B3DC-56FED9D55C50Q36644611-7DB19782-0955-455B-8A73-9EB0B1F0911DQ38664871-22FF686C-3ECF-47C5-8D5A-DA01BB860D0AQ39149738-9ABDEF2D-D0D5-4373-8A7D-9D58943DE542Q39400073-DA26BC68-2907-413F-AE2F-76A916B82A98Q40588136-9B5D6E3A-F210-4B6B-9825-760A48B4BD5FQ41570386-16B85C25-9336-4FBE-9794-37E007E26C0DQ42369923-5696E156-7985-4B56-A98A-DCF594B34C79Q45014634-89A42EC1-7E00-4815-B048-E63B6923EAA5Q47381610-FDAD7482-332B-48FB-A6C8-A4233874A6DF
P2860
Potentiation of antibacterial activity of azithromycin and other macrolides by normal human serum.
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
1992年论文
@zh
1992年论文
@zh-cn
name
Potentiation of antibacterial ...... rolides by normal human serum.
@en
Potentiation of antibacterial ...... rolides by normal human serum.
@nl
type
label
Potentiation of antibacterial ...... rolides by normal human serum.
@en
Potentiation of antibacterial ...... rolides by normal human serum.
@nl
prefLabel
Potentiation of antibacterial ...... rolides by normal human serum.
@en
Potentiation of antibacterial ...... rolides by normal human serum.
@nl
P2860
P356
P1476
Potentiation of antibacterial ...... rolides by normal human serum.
@en
P2093
P2860
P356
10.1128/AAC.36.1.10
P407
P577
1992-01-01T00:00:00Z